Agilent Technologies, Inc. (A) is a Medical - Diagnostics & Research company in the Healthcare sector, currently trading at $120.40. It has a SharesGrow Score of 74/100, indicating a above average investment profile with 5 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of A = $120.45 (+0% from the current price, the stock appears fairly valued). Analyst consensus target is A = $168 (+39.7% upside).
Valuation: A trades at a trailing Price-to-Earnings (P/E) of 25.2 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.49.
Financials: revenue is $6.9B, +0.6%/yr average growth. Net income is $1.3B, growing at +1.3%/yr. Net profit margin is 18.8% (healthy). Gross margin is 52.4% (-2 pp trend).
Balance sheet: total debt is $3.4B against $6.7B equity (Debt-to-Equity (D/E) ratio 0.5, moderate). Current ratio is 1.96 (strong liquidity). Debt-to-assets is 26.4%. Total assets: $12.7B.
Analyst outlook: 29 / 38 analysts rate A as buy (76%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 58/100 (Partial), Growth 45/100 (Partial), Past 100/100 (Pass), Health 83/100 (Pass), Moat 76/100 (Pass), Future 85/100 (Pass), Income 70/100 (Pass).
